References
- Gleiter CH Mörike KE Clinical pharmacokinetics of candesartan Clin Pharmacokinet 2002 41 1 7 17 11825094
- Husain A Azim MS Mitra M Bhasin PS A review on candesartan: pharmacological and pharmaceutical profile Journal of Applied Pharmaceutical Science 2011 1 10 12 17
- Sweetman SC Martindale: The Complete Drug Reference 36th ed New York, NY Pharmaceutical Press 2009 1238 1239
- The European Agency for the Evaluation of Medicinal Products (EMA) Committee for Proprietary Medicinal Products (CPMP) Note for Guidance on the Investigation of Bioavailability and Bioequivalence. CPMP/EWP/QWP/1401/98 Rev.1 2010 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/01/WC500070039 Accessed August 7, 2013
- [Indonesian Guideline for Bioequivalence Studies] Badan Pengawas Obat dan Makanan Republik Indonesia (BPOM RI) Pedoman Uji Bioekuivalensi Jakarta Badan Pengawas Obat dan Makanan 2004 Bahasa
- World Medical Association Declaration of Helsinki Recommendations Guiding Physicians in Biomedical Research Involving Human Patients. Amended by the 52nd WMA General Assembly Edinburgh Scotland World Medical Association 2000
- International Conference on Harmonisation Expert Working Group ICH Harmonised Tripartite Guideline: Guideline for Good Clinical Practice E6 (R1) Geneva, Switzerland International Conference on Harmonisation 1996
- Organization for Economic Co-operation and Development OECD Series on Principles of Good Laboratory Practice and Compliance Monitoring Number 1: OECD Principles on Good Laboratory Practice Paris, France Organization for Economic Co-operation and Development 1997
- Prasad SVSGB Shivakumar S Sudhir T Mital R Devala Rao G LC/MS/MS method for the simultaneous estimation of losartan potassium and irbesartian in rat plasma International Journal of Pharmacy and Pharmaceutical Sciences 2009 1 Suppl 1 206 215
- Cooper-Dehoff RM Elliott WJ Generic drugs for hypertension: are they really equivalent? Curr Hypertens Rep 2013 15 4 340 345 23700299
- Kesselheim AS Misono AS Lee JL Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis JAMA 2008 300 21 2514 2526 19050195
- Jin X Han J [Studies on the bioequivalence of two candesartan preparations.] China Pharmacy 2007 11 Chinese
- Yu J Ma K Qi JW [Pharmacokinetics and bioequivalence of candesartan cilexetic tablet and capsule in healthy volunteers.] Chinese Journal of Clinical Pharmacology and Therapeutics 2009 7 Chinese
- Jeon JY Im YJ Kim Y Pharmacokinetic properties and bioequivalence of candesartan cilexetil in Korean healthy volunteers Drug Dev Ind Pharm Epub 10 3 2012
- Diletti E Hauschke D Steinijans VW Sample size determination for bioequivalence assessment by means of confidence intervals Int J Clin Pharmacol Ther Toxicol 1991 29 1 1 8 2004861